Low Incidence of Helicobacter pylori Infection in Patients with Duodenal Ulcer and Chronic Liver Disease

References

• Kabil SM, Moustafa MA, Moustafa RM. Studies on peptic ulceration and portal hypertension in patients with schistosomiasis (abstract). XII International Congress for Tropical Medicine and Malaria. Calgary, Alberta, Canada; 1984: 72.
   Google Scholar
• Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995;42: 424–7.
   Google Scholar
• Chen LS, Lin HC, Lee FY, Hou MC, Lee SD. Prevalence of duodenal ulcer in cirrhotic patients and its relation to Helicobacter pylori and portal hypertension. Chung Hua I Hsueh Tsa Chih (Taipei) 1995;56:226–31.
   Google Scholar
• Walker S, Klotz U, Sarem-Aslani A, Treiber G, Bode JC. Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine. Digestion 1991; 48:179–84.
   Google Scholar
• El-Newihi HM, Kanji VK, Mihas AA. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastro-pathy. Am J Gastroenterol 1996;91:535–8.
   Google Scholar
• Elashoff JD, Van Deventer G, Reedy TJ, Ippoliti A, Samloff IM, Kurata J, et al. Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol 1983;5:509–15.
   PubMed Web of Science ®Google Scholar
• Petersen H, Kristensen P, Johannessen T, Kleveland PM, Dybdahl JH, Myrvold H. The natural course of peptic ulcer disease and its predictors. Scand J Gastroenterol 1995;30:17–24.
   PubMed Web of Science ®Google Scholar
• Bate CM, Wilkinson SP, Bradby GV, Bateson MC, Hislop WS, Crowe JP, et al. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 1989;30:1323–8.
   PubMed Web of Science ®Google Scholar
• Dehn TC, Shepherd HA, Colin-Jones D, Kettlewell MG, Carroll NJ. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 1990;31: 509–13.
   Google Scholar
• Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994;107:1305–11.
   Google Scholar
• Wise MA, Van Ness MM. Bismuth. In: Van Ness MM, Gurney MS, Jones DM, editors. Handbook of gastrointestinal drug therapy. 2nd ed. Boston: Little, Brown; 1995. p. 59–63.
   Google Scholar
• Sauvet P, Schouler L. Omeprazole and liver functions [French]. Rev Med Interne 1992;13:359–63.
   PubMedGoogle Scholar
• Lomas RW, Smith JL. Medical treatment of peptic ulcer disease. Curr Opin Gastroenterol 1992;8:934–40.
   Google Scholar
• McFarland RJ, Bateson MC, Green JRB, O’Donoghue DP, Dronfield MW, Keeling PWN, et al. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology 1990;98:278–83.
   Google Scholar
• Valenzuela JE, Berlin RG, Snape WJ, Johnson TL, Hirschowitz BI, Colon-Pagan J, et al. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. Dig Dis Sci 1991;36:761–8.
   Google Scholar
• Carboni M, Van Ness MM. Omeprazole. In: Van Ness MM, Gurney MS, Jones DM, editors. Handbook of gastrointestinal drug therapy. 2nd ed. Boston: Little, Brown; 1995. p. 73–8.
   Google Scholar
• Nardone G, D’Armiento F, Del Pezzo M, Pontillo M, Budillon G. Diagnostic tests for Helicobacter pylori (Hp) infection in cirrhotic and non-cirrhotic patients [Abstract]. Endoscopy 1992; 24:624–5.
   Google Scholar
• Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM, Kuo CH. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 1994;39:1565–8.
   PubMed Web of Science ®Google Scholar
• Bhargava N, Venkateswaran S, Ramakrishna BS, Mathan M. Colonization by Helicobacter pylori and its relationship to histological changes in the gastric mucosa in portal hypertension. J Gastroenterol Hepatol 1994;9:507–11.
   PubMedGoogle Scholar
• Misra SP, Dwivedi M, Misra V, Agarwal SK, Gupta R, Gupta SC, et al. Endoscopic and histologic appearance of the gastric mucosa in patients with portal hypertension. Gastrointest Endosc 1990;36:575–9.
   PubMedGoogle Scholar
• Aymard B, Labouyrie E, de Korwin JD, Ferry R, Duprez A. Histological staining methods for detection of gastric campylobacter like organisms (GCLOs): a comparative study [ Abstract]. Gastroenterology 1988;94:A16.
   Google Scholar
• Khulusi S, Mendall MA, Patel P, Levy J, Badve S, Northfield TC. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 1995;37:319–24.
   PubMed Web of Science ®Google Scholar
• Cales P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990;98:156–62.
   Google Scholar
• D’Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano C, et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990;99:1558–64.
   Google Scholar
• McCormick PA, Sankey EA, Cardin F, Dhillon AP, McIntyre N, Burroughs AK. Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut 1991;32:351–4.
   PubMed Web of Science ®Google Scholar
• Di Mario F, Gottardello L, Germana B, Dotto P, Grassi SA, Vianello F, et al. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol 1992;24:122–5.
   PubMedGoogle Scholar
• Bayerdörffer E, Miehlke S, Mannes GA, Sommer A, Höchter W, Weingart J, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412–7.
   Google Scholar
• Cuzzocrea S, Zingarelli B, Villari D, Caputi AP, Longo G. Evidence for in vivo peroxynitrite production in human chronic hepatitis. Life Sci 1998;63:L25–30.
   Google Scholar
• Stachura J, Konturek JW, Karczewska A, Domschke W, Popiela T, Konturek SJ. Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactivity in vivo and in vitro. J Physiol Pharmacol 1996;47:131–5.
   PubMedGoogle Scholar
• Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996;24:439–50.
   Google Scholar
• Watanabe S, Takagi A, Koga Y, Kamiya S, Miwa T. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J Gastroenterol Hepatol 2000; 15:168–74.
   Google Scholar
• Zhang Q, Dawodu JB, Etolhi G, Husain A, Gemmell CG, Russell RI. Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer. Eur J Gastroenterol Hepatol 1997; 9:261–5.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H, et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 1992;263:G719–25.
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska K, Tkaczewski W, Blaszczyk J, Buczyn’ski A, Chojnacki J, Kedziora J. Oxygen metabolism in blood of patients with gastric and duodenal ulcer disease. Hepatogastroenterology 1995;42:246–9.
   Google Scholar
• Klinowski E, Broide E, Varsano R, Eshchar J, Scapa E. Superoxide dismutase activity in duodenal ulcer patients. Eur J Gastroenterol Hepatol 1996;8:1151–5.
   PubMedGoogle Scholar
• Galaktionova LP, Molchanov AV, El’chaninova SA, Varshavskii BI. Lipid peroxidation in patients with gastric and duodenal peptic ulcers [Russian]. Klin Lab Diagn 1998 June: 10–4.
   Google Scholar